Home » Topics » Regulatory

Regulatory
RSS

Forest files for FDA approval of Synapton

Nov. 26, 1997

First marketing approval granted for Neumega

Nov. 26, 1997

Extended-release Effexor introduced in U.S. for depression

Nov. 26, 1997

Neuroprotective efficacy of lamotrigine in rat cardiac arrest model

Nov. 25, 1997

FDA approves sibutramine for the treatment of obesity

Nov. 25, 1997

Fixed-dose trandolapril/verapamil combination now available in U.K.

Nov. 25, 1997

Combivir recommended for approval in Europe

Nov. 24, 1997

Novartis launches once-monthly formulation of Sandostatin

Nov. 24, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

FDA advisory committee recommends approval of Rocephin for AOM

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...